Login
$ABUS
$4.29 +$0.09 (2.02%) Live

Company Executives

$ABUS Management Team

Ms. Lindsay Androski

Chairman of the Board

President

Chief Executive Officer

Age 48
Compensation -
Sex Female

Mr. Tuan Nguyen

Chief Financial Officer

Age 49
Compensation -
Sex Male
Directors
5
serving now
Independent
Not stated
the proxy does not say
Average tenure
1.0 years
from year joined
CEO also chairs the board
Yes
Lindsay Androski
Director Age On board Independent Committees Other public boards 2025 pay Source
Lindsay Androski
49 2025
1 year
Not stated None stated None stated Paid as CEO
Robert Alan Beardsley
65 2025
1 year
Not stated None stated Inflamax, Metallomix, Euclises Pharmaceuticals $417,974
Joseph Bishop
51 2025
1 year
Not stated None stated None stated Not stated
Matthew Gline
41 2025
1 year
Not stated None stated Datavant Not stated
Roger Sawhney
56 2025
1 year
Not stated None stated Actuate Therapeutics, Adlai Nortye, Bobcat Bio $387,961

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 14, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support